Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|November 1, 2020
A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19Emre Yekedüz, Güngör Utkan, Yüksel Ürün
Future Oncology (London, England)|January 12, 2022
Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitorsEmre Yekedüz, Güngör Utkan, Yüksel Ürün
World Journal of Gastroenterology|April 9, 2015
Lower folate levels in gastric cancer: is it a cause or a result?Ali Alkan, Dılşa Mızrak, Güngör Utkan
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 20, 2021
Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle?Emre Yekedüz, Güngör Utkan, Yüksel Ürün
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 7, 2020
Topical aloe vera for the treatment of cetuximab-related acneiform rash in colorectal cancer: A case reportMustafa Gürbüz, Erman Akkuş, Güngör Utkan
Journal of Gastrointestinal Cancer|February 5, 2025
Low-Density Lipoprotein (LDL) is Associated with Earlier Progression in Synchronous Metastatic Colorectal Cancer Treated without Curative IntentErman Akkus, Nejat Emre Öksüz, Güngör Utkan
Molecular Imaging and Radionuclide Therapy|May 6, 2020
Intense 18F-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial PlexopathyÇiğdem Soydal, Pınar Akkuş, Mine Araz, et al.
Cureus|May 20, 2022
Genomic Landscape of Actionable Mutations in Primary and Metastatic Tissues of Colon AdenocarcinomaEmre Yekedüz, Hakan Akbulut, Güngör Utkan, et al.
Prostate International|April 29, 2021
Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?Emre Yekedüz, Güngör Utkan, Ravindran Kanesvaran, et al.
The Prostate|July 28, 2022
Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitorsSatı Coşkun Yazgan, Emre Yekedüz, Güngör Utkan, et al.
Pageof 6